About AgeX Therapeutics, Inc.
AgeX Therapeutics, Inc. operates as a biotechnology company. It focuses on the development and commercialization of novel therapeutics targeting human aging. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA.
At the moment the company generates 1M USD in revenues.
On its last earning announcement, the company reported a loss of -0.31$ per share.
The book value per share is 0.18$
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|